What Is BPC-157 Used For in Research?

BPC-157 stands for "Body Protection Compound-157." It is a pentadecapeptide (15 amino acids) first isolated from a partial sequence found in human gastric juice, then synthesized for laboratory use. Because it does not occur naturally as a standalone molecule outside the body, every batch sold for research is chemically synthesized rather than extracted.

The bulk of the published literature on BPC-157 comes from rodent and in-vitro models. Researchers have used it to study angiogenesis (new blood vessel formation), fibroblast migration, and modulation of the nitric oxide and growth-hormone-receptor pathways — mechanisms relevant to how tissue heals after injury. A separate body of research looks at gut-lining protection in chemically induced ulcer models.

Human clinical trial data on BPC-157 is limited, and no regulatory authority — not the FDA, not the UAE Ministry of Health and Prevention — has approved it for any therapeutic indication. It is classified in most jurisdictions, including the UAE, as a research chemical only. REVIVE LAB UAE's BPC-157 is sold exclusively to verified research buyers for laboratory use, with a Certificate of Analysis confirming identity and purity — not for human or veterinary administration.